Factor XI, a coagulation factor that is part of the intrinsic blood clotting pathway, is part of a newly discovered circuit that links coagulation, inflammation and hypertension. Researchers described the circuit, which breaks ground scientifically as well as offering potential therapeutic strategies to treat often-co-morbid diseases, in the Feb. 1, 2017, issue of Science Translational Medicine.